Above and Beyond Cancer Therapy: Translating Biomaterials into the Clinic

Research output: Contribution to journalShort survey

Abstract

Given extensive reports of anticancer nanomedicines in preclinical studies, why is there such a paucity of clinical trials using these therapies? Nanotechnology can certainly deliver, but we need to tackle the limitations that are impeding the translation of nanomedicines into the clinic and start benefiting from their full potential.

Original languageEnglish
JournalTrends in Cancer
DOIs
Publication statusAccepted/In press - 2020

    Fingerprint

Keywords

  • biomaterials
  • cancer therapy
  • clinical translation
  • nanomedicine

Cite this